Daxor Share Holder Equity 2012-2011 | DXR

Daxor share holder equity from 2012 to 2011. Share holder equity can be defined as the sum of preferred and common equity items
Daxor Annual Share Holder Equity
(Millions of US $)
2011 $36
Daxor Quarterly Share Holder Equity
(Millions of US $)
2011-12-31 $36
2011-09-30 $38
2011-06-30 $46
2011-03-31 $46
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.062B $0.000B
Daxor Corporation is a medical device manufacturing corporation with additional biotech services.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $31.902B 16.09
Quest Diagnostics (DGX) United States $20.580B 19.15
Elanco Animal Health (ELAN) United States $12.297B 25.78
Encompass Health (EHC) United States $9.441B 18.15
DaVita (DVA) United States $7.850B 10.24
Chemed (CHE) United States $6.165B 21.66
Option Care Health (OPCH) United States $5.494B 23.39
RadNet (RDNT) United States $5.467B 186.50
LifeStance Health (LFST) United States $2.793B 0.00
Addus HomeCare (ADUS) United States $1.947B 20.10
Aveanna Healthcare Holdings (AVAH) United States $1.740B 21.92
U.S Physical Therapy (USPH) United States $1.272B 32.18
Astrana Health (ASTH) United States $1.256B 117.47
Pennant (PNTG) United States $0.976B 32.44
MEDIROM Healthcare Technologies (MRM) Japan $0.041B 0.00
Psychemedics (PMD) United States $0.000B 0.00